U.S. markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
595.40+4.27 (+0.72%)
At close: 04:00PM EDT
593.80 -1.60 (-0.27%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close591.13
Bid593.80 x 1000
Ask596.99 x 800
Day's Range586.17 - 597.00
52 Week Range538.01 - 747.42
Avg. Volume698,301
Market Cap65.402B
Beta (5Y Monthly)0.24
PE Ratio (TTM)8.39
EPS (TTM)71.00
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est689.18
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for REGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Regeneron Pharmaceuticals, Inc.
    Technical Assessment: Bearish in the Intermediate-TermWe have not talked much about small-cap stocks as they have steadily underperformed the S&P 500 since February 2021 and the S&P MidCap 400 since January 2021. Both the Russell 2000 (IWM) and the S&P SmallCap 600 (SML) peaked in November 2021 and have been tracing out lower lows and lower highs ever since. At the June 16 closing low, the IWM had cratered 32% while the SML had given up 26%. Interestingly, the hyper-revenue-growth/no-EPS stocks peaked in late 2020 and early 2021, well before the small-caps. The Nasdaq, QQQs and the S&P 500 all peaked in late 2021/early 2022.
    Fair Value
    Economic Moat
    10 days agoArgus Research
View more